Overview

Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain

Status:
Completed
Trial end date:
2016-04-15
Target enrollment:
Participant gender:
Summary
A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in pre-menopausal women.
Phase:
Phase 3
Details
Lead Sponsor:
AbbVie